Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.20.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
OPERATING ACTIVITIES    
Net income (loss) $ 3,722 $ (579)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Provision for doubtful accounts 523 (190)
Depreciation 4,782 3,676
Loss on disposal of medical equipment and other assets 77 303
Gain on sale of medical equipment (3,224) (837)
Amortization of intangible assets 2,150 2,249
Amortization of deferred debt issuance costs 9 19
Stock-based compensation 563 530
Deferred income taxes 12 76
Changes in assets - (Increase)/Decrease:    
Accounts receivable (2,115) (643)
Inventories (1,363) (488)
Other current assets 205 4
Other assets (123) (165)
Changes in liabilities - Increase/(Decrease):    
Accounts payable and other liabilities (956) 364
NET CASH PROVIDED BY OPERATING ACTIVITIES 4,262 4,319
INVESTING ACTIVITIES    
Purchase of medical equipment (8,783) (7,595)
Purchase of property and equipment (680) (298)
Proceeds from sale of medical equipment, property and equipment 971 1,333
NET CASH USED IN INVESTING ACTIVITIES (8,492) (6,560)
FINANCING ACTIVITIES    
Principal payments on term loans, equipment line, revolving credit facility and other financing (23,777) (2,256)
Cash proceeds from 2019 equipment line, revolving credit facility and other financing 26,259 2,024
Debt issuance costs (3)
Common stock repurchased to satisfy statutory withholding on employee stock-based compensation plans (741) (208)
Cash proceeds from stock plans 74 68
Common stock - issued 250
NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES 2,065 (375)
Net change in cash and cash equivalents (2,165) (2,616)
Cash and cash equivalents, beginning of period 2,647 4,318
Cash and cash equivalents, end of period $ 482 $ 1,702